China Pharma Hldgs Inc.
13F holders, Q2 2024 (June 30)4holders +1
4new positions
3sold out
$0.23avg. 13F price*
At the end of Q2 2024, 4 institutions reported holding China Pharma Hldgs Inc. in their 13F filings, up 1 from Q1 2024. 4 opened new positions and 3 sold out. The largest holders were XTX Topco Ltd ($7K), Baader Bank Aktiengesellschaft ($4K) and Susquehanna International Group, LLP ($3K).
- Company
- China Pharma Hldgs Inc.
- CUSIP
- 16941T302
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $14K |
| Exits | 3 | $43K |
All 13F filers, Q1 2024 → Q2 2024: 59,992 shares bought and 115,912 shares sold, net −55,920 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| XTX Topco Ltd | 0.00% | New | 28,737 | $7K |
| Baader Bank Aktiengesellschaft | 0.00% | New | 20,309 | $4K |
| Susquehanna International Group, LLP | 0.00% | New | 10,916 | $3K |
| First Community Trust NA | 0.00% | New | 30 | $7 |
"% of holder's portfolio" is CHINA PHARMA HLDGS INC's weight in each manager's 13F, not the share of China Pharma Hldgs Inc. the manager owns.